Drug intelligence / Profile preview

shox2 morpholino

Development stage
Preclinical
Modality
Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Microinjection
01

Overview

shox2 morpholino is a synthetic antisense oligonucleotide used as a research tool to knock down the expression of the Short stature homeobox 2 (shox2) gene. Morpholinos function by binding to complementary sequences of RNA, typically blocking the translation initiation complex or interfering with pre-mRNA splicing. In developmental biology, particularly in zebrafish models, shox2 morpholinos are employed to investigate the gene's role in the development of the heart, brain, and limbs. Research has indicated that shox2 deficiency leads to altered expression of fibroblast growth factor receptor 3 (fgfr3) and natriuretic peptides, providing insights into conditions like short stature and cardiac stress.

Other names
shox2 antisense morpholinoshox-2 antisense morpholinoshox 2 antisense morpholinoshox2 morpholino oligonucleotideshox-2 morpholino oligonucleotideshox 2 morpholino oligonucleotide
02

Targets

Short stature homeobox protein 2 pre-messenger RNA (SHOX2 pre-mRNA)SHOX (Short stature homeobox protein)

Beyond the preview

Go deeper on shox2 morpholino.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shox2 morpholino.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call